Susanne Staehlke | Cell-Biomaterial-Interaction | Best Researcher Award

Dr. Susanne Staehlke | Cell-Biomaterial-Interaction | Best Researcher Award

Rostock University Medical Center | Germany

Author Profile

Orcid 

📚 EARLY ACADEMIC PURSUITS

Dr. Susanne Staehlke began her academic journey with a focus on Genetic and Microbiology at the University of Rostock, Germany, from 2000 to 2006. During this time, she specialized in signal transduction in Oncorhynchus mykiss (rainbow trout), which laid the foundation for her interest in molecular biology and cell signaling. She continued her studies at Rostock University Medical Center, where she earned her PhD in Cell Biology in 2014. Her doctoral research focused on the interaction between human osteoblasts and geometrically structured implant surfaces, specifically investigating cell architecture and signal transduction.

đź’Ľ PROFESSIONAL ENDEAVORS

Dr. Staehlke’s career as a scientist includes an extensive background in cell biology, biomaterials, and tissue engineering. After earning her PhD, she embarked on post-doctoral research that expanded her expertise into ophthalmology, where she focused on understanding cell responses to surface modifications for ocular applications. Her work in this area also involved collaborations with experts in various fields, including engineering, physics, chemistry, and medicine, to enhance biomaterial designs for clinical applications. Throughout her career, Dr. Staehlke has contributed to over 40 publications, and her work has made significant strides in the fields of biomaterials and regenerative medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON Cell-Biomaterial-Interaction

Dr. Staehlke has made a profound impact in the fields of biomaterials, cell biology, and tissue engineering. Her primary research focus has been on optimizing cell-biomaterial interactions, particularly improving osteoblast responses to implant surfaces. By investigating physico-chemical surface modifications, such as plasma polymer coatings and topographical features, Dr. Staehlke’s work has advanced biomaterial design, enhancing cell behavior and implant integration. Additionally, her research in the integration of artificial intelligence (AI), machine learning, and big data analytics has enabled better prediction of cellular responses to various biomaterials. Her interdisciplinary approach has driven significant advancements in regenerative medicine, stem cell characterization, and biomedicines.

🌍 IMPACT AND INFLUENCE

Dr. Staehlke’s contributions to science have had a lasting influence on biomaterial innovation, tissue engineering, and regenerative medicine. Her work has led to groundbreaking advances in surface modifications for implants, improving both the functional and biological success of biomaterials. Dr. Staehlke has also been instrumental in enhancing the reproducibility of scientific research by advocating for rigorous data analysis methods and the development of open-source platforms for data management. Her interdisciplinary approach, which bridges cell biology with computational tools and engineering, has strengthened scientific rigor and fostered collaborations across diverse fields.

đź“‘ ACADEMIC CITES

Dr. Staehlke’s work has garnered significant academic recognition, with over 40 publications in leading journals within the fields of biomaterials, cell biology, and tissue engineering. Her research is widely cited, contributing to the advancement of knowledge in cell-biomaterial interactions. She has a citation index of 506 and an h-index of 12, demonstrating the profound impact and influence of her scholarly contributions.

🏛️ LEGACY AND FUTURE CONTRIBUTIONS

Dr. Staehlke’s legacy in the scientific community will likely continue to grow as her research paves the way for new biomaterial technologies and therapeutic applications in regenerative medicine. Her integration of AI and big data into cell biology and biomaterials research ensures that her future contributions will further refine predictive models for cellular behavior, ultimately improving patient outcomes in tissue engineering and implantology. As she continues to collaborate with experts from various disciplines, Dr. Staehlke’s work promises to influence both academic research and clinical practice for years to come.

🤝 KEY COLLABORATIONS

Throughout her career, Dr. Staehlke has worked closely with interdisciplinary teams, including engineers, clinicians, data scientists, and materials scientists. Her research has benefited from collaborations in the fields of ophthalmology, biomaterials, and systems biology. These partnerships have led to innovative approaches for improving cell-biomaterial interactions and advancing technologies in regenerative medicine. Additionally, her work with AI and machine learning specialists has allowed her to optimize experimental data analysis, which has been essential for ensuring reproducibility and improving the predictive accuracy of her research findings.

🧑‍🔬 PROFESSIONAL MEMBERSHIPS

Dr. Staehlke holds memberships in several professional organizations, including the German Society for Biomaterials (DGBM), TERMIS (Tissue Engineering and Regenerative Medicine International Society), and the German Ophthalmology Society (DOG). These memberships reflect her commitment to staying at the forefront of developments in her field and engaging with a global network of researchers and professionals.

📊 RESEARCH DATA ANALYSIS AWARDS

Dr. Staehlke’s research has also been recognized in the field of data analysis, particularly for her innovative approaches in handling complex datasets related to cell-biomaterial interactions. This dedication to data integrity and reproducibility has earned her numerous accolades and collaborations with experts in scientific workflows and AI-powered data analysis tools.

📑 NOTABLE PUBLICATIONS 

Impact of Metal Ions on Cellular Functions: A Focus on Mesenchymal Stem/Stromal Cell Differentiation
    • Authors: Kirsten Peters, Susanne Staehlke, Henrike Rebl, Anika Jonitz-Heincke, Olga Hahn
    • Journal: International Journal of Molecular Sciences
    • Year: 2024
Suppressing Pro-Apoptotic Proteins by siRNA in Corneal Endothelial Cells Protects against Cell Death
    • Authors: Susanne Staehlke, Siddharth Mahajan, Daniel Thieme, Peter Trosan, Thomas A. Fuchsluger
    • Journal: Biomedicines
    • Year: 2024
Cold Atmospheric Pressure Plasma-Activated Medium Modulates Cellular Functions of Human Mesenchymal Stem/Stromal Cells In Vitro
    • Authors: Olga Hahn, Tawakalitu Okikiola Waheed, Kaarthik Sridharan, Thomas Huemerlehner, Susanne Staehlke, Mario ThĂĽrling, Lars Boeckmann, Mareike Meister, Kai Masur, Kirsten Peters
    • Journal: International Journal of Molecular Sciences
    • Year: 2024
The Impact of Ultrashort Pulse Laser Structuring of Metals on In-Vitro Cell Adhesion of Keratinocytes
    • Authors: Susanne Staehlke, Tobias Barth, Matthias Muench, Joerg Schroeter, Robert Wendlandt, Paul Oldorf, Rigo Peters, Barbara Nebe, Arndt-Peter Schulz
    • Journal: Journal of Functional Biomaterials
    • Year: 2024
Short-Time Alternating Current Electrical Stimulation and Cell Membrane-Related Components
    • Authors: Maren E. Buenning, Meike Bielfeldt, Barbara Nebe, Susanne Staehlke
    • Journal: Applied Sciences
    • Year: 2024

farnaz shokraneh | personalized medicine | Best Researcher Award

Ms. farnaz shokraneh | personalized medicine | Best Researcher Award

Abo Akademi University, Finland

👨‍🎓Professional Profile 

Orcid Profile

👩‍🔬 Summary

Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Ă…bo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.

🎓 Education

Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).

đź’Ľ Professional Experience

Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).

🛠️ Technical Skills

Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.

🧑‍🏫 Teaching Experience

Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.

🔬 Research Interests

Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.

 

đź“–Top Noted Publications

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.

Journal: Pharmaceutics

Year: 2024

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Authors: Farnaz Shokraneh

Journal: Iranian Journal of Pharmaceutical Research

Year: 2014

Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)

Authors: Farnaz Shokraneh

Journal: FIP Congress

Year: 2012

Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations

Authors: Farnaz Shokraneh

Journal: Research in Pharmaceutical Science

Year: 2012

A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies

Authors: Farnaz Shokraneh

Journal: Oriental Journal of Chemistry

Year: 2012

Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics

Authors: Farnaz Shokraneh

Journal: EXCLI Journal

Year: 2005